Sean H. Lim

2.1k total citations
33 papers, 1.2k citations indexed

About

Sean H. Lim is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sean H. Lim has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Sean H. Lim's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Sean H. Lim is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Sean H. Lim collaborates with scholars based in United Kingdom, United States and Australia. Sean H. Lim's co-authors include Mark S. Cragg, Stephen A. Beers, Peter Johnson, Ruth R. French, Martin J. Glennie, H.T. Claude Chan, M J Glennie, Kerry L. Cox, Sandra V. Dixon and Ronald Levy and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sean H. Lim

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sean H. Lim United Kingdom 13 552 531 417 386 385 33 1.2k
Marie‐Christine Jacob France 21 563 1.0× 181 0.3× 326 0.8× 240 0.6× 331 0.9× 66 1.4k
Sophie de Guibert France 18 846 1.5× 135 0.3× 456 1.1× 566 1.5× 640 1.7× 42 1.6k
Zale P. Bernstein United States 19 513 0.9× 111 0.2× 397 1.0× 571 1.5× 549 1.4× 60 1.6k
J. L. Garnier France 15 258 0.5× 306 0.6× 913 2.2× 93 0.2× 254 0.7× 32 1.3k
Martine E.D. Chamuleau Netherlands 21 660 1.2× 275 0.5× 713 1.7× 325 0.8× 586 1.5× 103 1.6k
Tycel Phillips United States 22 367 0.7× 142 0.3× 899 2.2× 554 1.4× 956 2.5× 149 1.6k
William Townsend United Kingdom 22 375 0.7× 371 0.7× 877 2.1× 365 0.9× 897 2.3× 68 1.8k
Robert Wasserman United States 18 945 1.7× 314 0.6× 344 0.8× 261 0.7× 177 0.5× 35 1.8k
Marc André Belgium 19 120 0.2× 218 0.4× 731 1.8× 329 0.9× 1.1k 2.9× 121 1.7k
RA Warnke United States 14 365 0.7× 162 0.3× 345 0.8× 257 0.7× 531 1.4× 31 992

Countries citing papers authored by Sean H. Lim

Since Specialization
Citations

This map shows the geographic impact of Sean H. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean H. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean H. Lim more than expected).

Fields of papers citing papers by Sean H. Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean H. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean H. Lim. The network helps show where Sean H. Lim may publish in the future.

Co-authorship network of co-authors of Sean H. Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Sean H. Lim. A scholar is included among the top collaborators of Sean H. Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean H. Lim. Sean H. Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mumford, Lisa, Rachel Hogg, Peter Lanyon, et al.. (2025). Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study. The Lancet. 405(10475). 314–328. 1 indexed citations
2.
3.
4.
Rohrberg, Kristoffer Staal, Zsuzsanna Pápai, Rikke Løvendahl Eefsen, et al.. (2024). 19-BI-1808-01, a phase 1/2a clinical trial of BI-1808, a tumor necrosis factor receptor 2 (TNFR2) blocker/depleter with or without pembrolizumab.. Journal of Clinical Oncology. 42(16_suppl). 2641–2641. 1 indexed citations
5.
Zhou, Jing, Amy Tam, Sean H. Lim, et al.. (2023). Exploring Parametric and Mechanistic Differences between Expi293FTM and ExpiCHO-STM Cells for Transient Antibody Production Optimization. Antibodies. 12(3). 53–53. 7 indexed citations
6.
Lim, Sean H., Stephen A. Beers, Aymen Al‐Shamkhani, & Mark S. Cragg. (2023). Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. Clinical Cancer Research. 30(9). 1712–1723. 9 indexed citations
7.
Roy, Ashok, et al.. (2023). Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate. PLoS ONE. 18(8). e0290571–e0290571. 9 indexed citations
8.
Mårtensson, Linda, Kirstie L.S. Cleary, Benjamin L. Duell, et al.. (2023). 1368 Preclinical development of an agonistic anti-TNFR2 antibody (BI-1910) for cancer immunotherapy. SHILAP Revista de lepidopterología. A1524–A1524. 1 indexed citations
9.
Federspiel, Joel D., Mireia Fernández Ocaña, Sean H. Lim, et al.. (2023). Complement Activation by Adeno-Associated Virus-Neutralizing Antibody Complexes. Human Gene Therapy. 34(11-12). 554–566. 24 indexed citations
10.
Pearce, Fiona, Sean H. Lim, Mary Bythell, et al.. (2023). Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY. The Lancet Rheumatology. 5(8). e461–e473. 11 indexed citations
11.
Chan, H.T. Claude, Michael J. Marshall, Christine A. Penfold, et al.. (2022). Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering. Communications Biology. 5(1). 229–229. 12 indexed citations
12.
Lim, Sean H., Nicola Campbell, Marina Johnson, et al.. (2021). Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma. The Lancet Haematology. 8(8). e542–e544. 47 indexed citations
13.
Roghanian, Ali, Guangan Hu, Christophe Fraser, et al.. (2019). Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression. Cancer Immunology Research. 7(11). 1876–1890. 29 indexed citations
14.
Cox, Kerry L., Christine A. Penfold, Ruth R. French, et al.. (2018). Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking. Scientific Reports. 8(1). 2278–2278. 30 indexed citations
15.
Lim, Sean H., Kim Linton, Graham P. Collins, et al.. (2018). RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial. Trials. 19(1). 619–619. 8 indexed citations
16.
MacDonald, David & Sean H. Lim. (2017). Extranodal lymphoma arising within the maxillary alveolus: a systematic review. Oral Radiology. 34(2). 113–126. 10 indexed citations
17.
Alduaij, Waleed, Andrei Ivanov, Jamie Honeychurch, et al.. (2011). Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies. Blood. 117(17). 4519–4529. 222 indexed citations
18.
Beers, Stephen A., Ruth R. French, H.T. Claude Chan, et al.. (2010). Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection. Blood. 115(25). 5191–5201. 241 indexed citations
19.
Lim, Sean H., Stephen A. Beers, Ruth R. French, et al.. (2009). Anti-CD20 monoclonal antibodies: historical and future perspectives. Haematologica. 95(1). 135–143. 180 indexed citations
20.
Lim, Sean H., et al.. (2006). Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency. Blood Coagulation & Fibrinolysis. 17(8). 667–671. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Christine Jacob Breakdown of academic impact, for papers by Sophie de Guibert Breakdown of academic impact, for papers by Zale P. Bernstein Breakdown of academic impact, for papers by J. L. Garnier Breakdown of academic impact, for papers by Martine E.D. Chamuleau Breakdown of academic impact, for papers by Tycel Phillips Breakdown of academic impact, for papers by William Townsend Breakdown of academic impact, for papers by Robert Wasserman Breakdown of academic impact, for papers by Marc André Breakdown of academic impact, for papers by RA Warnke
Rankless by CCL
2026